Contrast Enhanced Ultrasound in Liver Metastases Diagnosis
Abstract
Results of contrast enhanced ultrasound in 3 patients with liver metastases are presented. The first case presents data of contrast enhanced ultrasound in diagnosis of multiple metastases of neuroendocrine pancreatic tumor which were not visualized in B-mode. Second and third cases (rectal cancer with liver metastases) did not show any new lesions in compare with B-mode.
Keywords
ультразвуковое исследование с контрастным усилением,
ультразвуковой контрастный препарат,
Соновью,
артериальная фаза,
портальная венозная фаза,
поздняя фаза,
печень,
метастазы,
contrast enhanced ultrasound (CEUS),
ultrasound contrast agent (UCA),
SonoVue,
arterial phase,
portal venous phase,
late phase,
liver,
metastases
About the Authors
A. S. Ageev
N.N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
M. A. Chekalova
N.N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
Yu. I. Patyutko
N.N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
A. N. Polyakov
N.N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
A. G. Margaryan
N.N. Blokhin Russian Cancer Research Center
Russian Federation
Russian Federation
References
1. Wilson S.R., Burns P.N. An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography // Am. J. Roentgenol. 2006. V. 186. No. 5. P. 1401-1412.
2. Leen E., Ceccotti P., Kalogeropoulou C., Angerson W.J., Moug S.J., Horgan P.G. Prospective multicenter trial evaluating a novel method of characterizing focal liver lesions using contrast-enhanced sonography // Am. J. Roentgenol. 2006. V. 186. No. 6. P. 1551-1559.
3. Ding H., Wang W.P., Huang B.J., Wei R.X., He N.A., Qi Q., Li C.L. Imaging of focal liver lesions: low-mechanical-index real-time ultrasonography with SonoVue // J. Ultrasound Med. 2005. V. 24. No. 3. P. 285-297.
4. Quaia E., Degobbis F., Tona G., Mosconi E., Bertolotto M., Pozzi Mucelli R. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue // Radiol. Med. 2004. V. 107. No. 3. P. 155-165.
5. Quaia E., Calliada F., Bertolotto M., Rossi S., Garioni L., Rosa L., Pozzi-Mucelli R. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence // Radiology. 2004. V. 232. No. 2. P. 420-430.
6. Greis C. Technology overview: SonoVue (Bracco, Milan) // Eur. Radiol. 2004. V. 14. Suppl. 8. P. 11-15.
7. Morel D.R., Schwieger I., Hohn L., Terrettaz J., Llull J.B., Cornioley Y.A., Schneider M. Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging // Invest. Radiol. 2000. V. 35. No. 1. P. 80-85.
8. Lampaskis M., Averkiou M. Investigation of the relationship of nonlinear backscattered ultrasound intensity with microbubble concentration at low MI // Ultrasound Med. Biol. 2010. V. 36. No. 2. P. 306-312.
Review
For citations:
Ageev A.S., Chekalova M.A., Patyutko Yu.I., Polyakov A.N., Margaryan A.G. Contrast Enhanced Ultrasound in Liver Metastases Diagnosis. Ultrasound & Functional Diagnostics. 2016;(2):9-16. (In Russ.)
Views:
69
Email this article 